# Xylocaine

NDC: 63323-485
Generic name: LIDOCAINE HYDROCHLORIDE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INFILTRATION, PERINEURAL
Marketing started: 20100812

FDA application: NDA006488

## Active ingredients

- LIDOCAINE HYDROCHLORIDE ANHYDROUS: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-485"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-485
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dd52202-8eef-4136-92dd-ada573b7cf74